SCHEMBL16628710

SCHEMBL16628710

Nc1nc(C(=O)N2Cc3ccccc3C2)c2cc(Cl)ccc2n1

nearest known ligand 0.76

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.76
HSP90AB1 P08238 3/20 0.76
EGFR P00533 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAOB P27338 1/20 0.42
SPR P35270 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3094214 0.90 HSP90AA1 (0.73) HSP90AA1HSP90AB1SMN1; SMN2SPRTAS1R3
SCHEMBL16628709 0.88 HSP90AA1 (0.80) HSP90AA1HSP90AB1SMN1; SMN2KDM4ELMNA
SCHEMBL3093783 0.88 HSP90AA1 (0.77) HSP90AA1HSP90AB1MAOBHTT
SCHEMBL16628686 0.86 HSP90AA1 (1.00) HSP90AA1HSP90AB1SMN1; SMN2MAOB
SCHEMBL12199647 0.86 HSP90AA1 (0.73) HSP90AA1HSP90AB1SMN1; SMN2KDM4ELMNA
SCHEMBL16628804 0.85 HSP90AA1 (0.76) HSP90AA1HSP90AB1SMN1; SMN2TAS1R3TAS1R1
SCHEMBL12199578 0.85 HSP90AA1 (1.00) HSP90AA1HSP90AB1SMN1; SMN2KDM4ELMNA
SCHEMBL903930 0.85 HSP90AA1 (0.76) HSP90AA1HSP90AB1SMN1; SMN2KDM4ELMNA
SCHEMBL3085489 0.85 HSP90AA1 (0.76) HSP90AA1HSP90AB1SMN1; SMN2KDM4EHTT
SCHEMBL3095799 0.85 HSP90AA1 (0.76) HSP90AA1HSP90AB1SMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed